Brentuximab VEDOTIN este inca un medicament inca experimental, dar care in Anglia a inceput sa fie folosit in spitale pentru tratarea Limfomului non-Hodgkin. “… Brentuximab vedotin (INN, trade name Adcetris) is an antibody-drug conjugate (ADC) directed to the protein CD30, which is expressed in classical Hodgkin lymphoma (HL) and systemic anaplastic large cell lymphoma (sALCL)….” Limfomul […]
↧